Streptococcus pyogenes infections with limited emm-type diversity in the homeless population of Brussels, 2016-2018.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 16 11 2018
revised: 15 01 2019
accepted: 17 01 2019
pubmed: 27 1 2019
medline: 2 7 2019
entrez: 27 1 2019
Statut: ppublish

Résumé

The aim was to characterize the clinical features, outcomes, and strain diversity of laboratory-confirmed Streptococcus pyogenes (group A Streptococcus, GAS) infections among inpatients hospitalized at a tertiary level hospital in Brussels, Belgium, according to the patients' housing status (homeless vs. not homeless). Between August 2016 and January 2018, all patients hospitalized with a laboratory-confirmed GAS infection were prospectively enrolled and risk factors were recorded. GAS strains were characterized using emm-typing and emm-clustering in both inpatients and outpatients. Analyses were performed according to homelessness status. During the study period, 48% (28/58) of adults hospitalized with a GAS infection at the tertiary hospital were homeless. The estimated incidence rate was 100 times higher for homeless persons. Skin abscesses were more frequent in the homeless group (21.4% vs. 3.3%) and mortality was high (10.7%). Limited emm-type diversity was found in this group, with four emm-types (64, 77, 83, and 101) accounting for 76.1% of the infections, and the majority of these emm-types belonged to the D4 emm-cluster. Pooled analyses of inpatient and outpatient strains indicated lower diversity in the homeless group. The homeless are disproportionately affected by GAS and have a higher rate of abscesses and high mortality. The lower emm-type diversity and preferential infection with four emm-types likely reflects endemic circulation of GAS in this population. Preventive strategies are warranted in this fragile population.

Identifiants

pubmed: 30684741
pii: S1201-9712(19)30037-2
doi: 10.1016/j.ijid.2019.01.026
pii:
doi:

Substances chimiques

Bacterial Outer Membrane Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

52-56

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Nicolas Dauby (N)

Centre Hospitalier Universitaire Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium; Centre for Environmental Health and Occupational Health, School of Public Health, Université Libre de Bruxelles (ULB). Electronic address: Nicolas.dauby@ulb.ac.be.

Véronique Yvette Miendje Deyi (VY)

Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium. Electronic address: Veronique.MIENDJEDEYI@lhub-ulb.be.

Valérie Delforge (V)

Molecular Bacteriology Laboratory, Université Libre de Bruxelles (ULB), Brussels, Belgium. Electronic address: valerie.delforge@ulb.ac.be.

Delphine Martiny (D)

Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium; Université de Mons (UMONS), Mons, Belgium. Electronic address: delphine.martiny@lhub-ulb.be.

Leila Mekkaoui (L)

Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium. Electronic address: leila.mekkaoui@lhub-ulb.be.

Marie Hallin (M)

Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium. Electronic address: marie.hallin@lhub-ulb.be.

Romain Mahieu (R)

Hygiene Inspection, Comission Communautaire Commune, Brussels-Capital Region, Brussels, Belgium. Electronic address: rmahieu@ccc.brussels.

Nathalie Bossuyt (N)

Epidemiology of Infectious Diseases, Sciensano, Brussels, Belgium. Electronic address: Nathalie.Bossuyt@sciensano.be.

Anne Botteaux (A)

Molecular Bacteriology Laboratory, Université Libre de Bruxelles (ULB), Brussels, Belgium. Electronic address: Anne.Botteaux@ulb.ac.be.

Pierre R Smeesters (PR)

Molecular Bacteriology Laboratory, Université Libre de Bruxelles (ULB), Brussels, Belgium; Queen Fabiola Children University Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium; Murdoch Children's Research Institute, Melbourne, Australia; Centre for International Child Health, University of Melbourne, Melbourne, Australia. Electronic address: psmeeste@ulb.ac.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH